Metabolic profiles of IgA nephropathy, membranous nephropathy, and diabetic nephropathy

<p><span><strong>Supplementary Figure 1 </strong>Quality control analysis (A) Pearson correlation between quality control samples (positive mode) (B) principal component (PC) plot of five groups (positive mode, 2 dimensions) (C) PC plot of five groups (positive mode, 3 dimensions) (D) Pearson correlation between QC samples (negative mode) (E) PC plot of five groups (negative mode, 2 dimensions) (F) PC plot of five groups (negative mode, 3 dimensions). <strong>Supplementary Figure 2 </strong>Heatmaps of differential metabolites (A) IgA nephropathy (IgAN) vs controls pair (positive mode) (B) membranous nephropathy (MN) vs controls pair (positive mode) (C) diabetic nephropathy (DN) vs controls pair (positive mode) (D) IgAN vs controls pair (negative mode) (E) MN vs controls pair (negative mode) (F) DN vs controls pair (negative mode). <strong>Supplementary table 1 </strong>List of differential metabolites in three comparison pairs (positive mode). <strong>Supplementary table 2 </strong>List of differential metabolites in three comparison pairs (negative mode). <strong>Supplementary table 3 </strong>KEGG enrichment pathways</span></p>